The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-chloro-4-(6-((1S,5S)-8-(cyclopropylsulfonyl)-8-azabicyclo[3.2.1]octan-3-yloxy)-5-methylpyrimidin-4-ylamino)benzonitrile ID: ALA3084389
PubChem CID: 53235503
Max Phase: Preclinical
Molecular Formula: C22H24ClN5O3S
Molecular Weight: 473.99
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(Nc2ccc(C#N)cc2Cl)ncnc1O[C@H]1C[C@H]2CC[C@@H](C1)N2S(=O)(=O)C1CC1
Standard InChI: InChI=1S/C22H24ClN5O3S/c1-13-21(27-20-7-2-14(11-24)8-19(20)23)25-12-26-22(13)31-17-9-15-3-4-16(10-17)28(15)32(29,30)18-5-6-18/h2,7-8,12,15-18H,3-6,9-10H2,1H3,(H,25,26,27)/t15-,16+,17+
Standard InChI Key: JONDVPWMQDOELC-FVQHAEBGSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
10.2298 -26.7260 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0548 -26.7269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4680 -26.0128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0562 -25.2979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2312 -25.2971 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8180 -26.0112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4694 -24.5839 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.9906 -23.0671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0576 -23.8690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5414 -23.4403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5697 -23.4403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4300 -22.6272 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.9194 -23.0516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0498 -24.1526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6701 -23.7757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2930 -26.0136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4666 -27.4417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9669 -22.8770 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
9.8007 -22.2642 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
9.0074 -21.9186 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.2988 -22.3412 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7159 -21.4960 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5848 -21.2101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5730 -20.3852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8645 -20.8078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0534 -28.1558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4651 -28.8707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0519 -29.5847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2269 -29.5839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8152 -28.8690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2284 -28.1550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8166 -27.4401 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9.8137 -30.2980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4005 -31.0121 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3 16 1 0
2 17 1 0
4 5 1 0
11 18 1 1
2 3 1 0
8 19 1 6
5 6 2 0
12 20 1 0
6 1 1 0
20 21 2 0
1 2 2 0
20 22 2 0
4 7 1 0
20 23 1 0
24 23 1 0
25 24 1 0
23 25 1 0
9 10 1 0
10 11 1 0
11 12 1 0
17 26 1 0
8 12 1 0
26 27 2 0
8 13 1 0
27 28 1 0
13 9 1 0
28 29 2 0
11 14 1 0
29 30 1 0
8 15 1 0
30 31 2 0
31 26 1 0
14 15 1 0
31 32 1 0
9 7 1 6
29 33 1 0
3 4 2 0
33 34 3 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 473.99Molecular Weight (Monoisotopic): 473.1288AlogP: 3.92#Rotatable Bonds: 6Polar Surface Area: 108.21Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.04CX Basic pKa: 3.69CX LogP: 3.54CX LogD: 3.54Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.68Np Likeness Score: -1.26
References 1. Xia Y, Chackalamannil S, Greenlee WJ, Jayne C, Neustadt B, Stamford A, Vaccaro H, Xu XL, Baker H, O'Neill K, Woods M, Hawes B, Kowalski T.. (2011) Discovery of a nortropanol derivative as a potent and orally active GPR119 agonist for type 2 diabetes., 21 (11): [PMID:21536438 ] [10.1016/j.bmcl.2011.04.035 ]